NCT07234877
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07234877 |
| Title | Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | European Organisation for Research and Treatment of Cancer - EORTC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | SVN | NLD | ITA | GRC | FRA | ESP | DEU | AUT |
CKB BOOST